Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G Aggressive pituitary tumors, Neuroendocrinology. 2015;101(2):87–104. https://doi.org/10.1159/000371806 Epub 2015 Jan 5 Review.
Lasolle H, Ilie MD, Raverot G. Aggressive prolactinomas: how to manage? Pituitary. 2020 Feb;23(1):70–7. https://doi.org/10.1007/s11102-019-01000-7 Review.
Bonneville JF. Magnetic resonance imaging of pituitary tumors. Front Horm Res 2016;45:97–120. https://doi.org/10.1159/000442327. Epub 2016 Mar 15.
Cottier JP, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology. 2000;215(2):463–9. DOI: 10.1148/radiology.215.2.r00ap18463
Sol YL, Lee SK, Choi HS, Lee YH, Kim J, Kim SH. Evaluation of MRI criteria for cavernous sinus invasion in pituitary macroadenoma J Neuroimaging. 2014 Sep-Oct;24(5):498–503. https://doi.org/10.1111/j.1552-6569.2012.00710.x. Epub 2012 Nov 15.
Bonneville JF, Cattin F, Racle A, Bouchareb M, Boulard D, Potelon P, et al. Dynamic CT of the laterosellar extradural venous spaces. AJNR Am J Neuroradiol. 1989 May-Jun;10(3):535–42.
Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33:610–7.
Micko ASG, Wöhrer A, Wolfsberger S, Knosp E. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. Neurosurg. 2015;122:803–11. DOI: 10.3171/2014.12.JNS141083
Xu XY, Wang RZ, Zhi ZYXZ. Performance of Knosp grade for cavernous sinus invasion of Cushing's disease. Chinese. 2019 Jan 29;99(5):388–90. https://doi.org/10.3760/cma.j.issn.0376-2491.2019.05.014.
Cao L, Chen H, Hong J, Ma M, Zhong Q, Wang S. Magnetic resonance imaging appearance of the medial wall of the cavernous sinus. J Neuroradiol. 2013;40:245–51. DOI: 10.1016/j.neurad.2013.06.003
Mooney MA, Hardesty DA, Sheehy JP, Bird R, Chapple K, White WL, et al. Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading. J Neurosurg. 2017 May;126(5):1714–9. 10.3171/2016.3.JNS153044. DOI: 10.3171/2016.3.JNS153044
Bonneville JF, Bonneville F, Cattin F, Nagi S, editors. Cavernous sinus invasion in MRI of the pituitary gland. Berlin, Germany: Springer; 2016. p. 77–83.
Bonneville JF. A plea for the T2W MR sequence for pituitary imaging. Pituitary. 2019 Apr;22(2):195–7. 10.1007/s11102-018-0928-9. DOI: 10.1007/s11102-018-0928-9
Potorac I, Beckers A, Bonneville JF. T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective. Pituitary. 2017 Feb;20(1):116–20. 10.1007/s11102-017-0788-8. DOI: 10.1007/s11102-017-0788-8
Balogun JA, Monsalves E, Juraschka K, Parvez K, Kucharczyk W, Mete O, et al. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol. 2015;26(1):63–70. https://doi.org/10.1007/s12022-014-9347-2 CrossRefPubMedGoogle Scholar 1.64.
Brochier S, Galland F, Kujas M, Parker F, Gaillard S, Raftopoulos C, et al. Factors predicting relapse of nonfunctioning pituitary macroadenomas afterneurosurgery: a study of 142 patients. Eur J Endocrinol. 2010;163(2):193–200. 10.1530/eje-10-0255. DOI: 10.1530/eje-10-0255
Drummond J, Roncaroli F, Grossman A B, Korbonits M. Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab. 2019 Jul; 104(7): 2473–2489. Published online 2018 Jul 17. https://doi.org/10.1210/jc.2018-00688.
Ben-Shlomo A, Cooper O. Silent corticotroph adenomas. Pituitary. 2018;21(2):183–93. DOI: 10.1007/s11102-018-0864-8
Cazabat L, Dupuy M, Boulin A, Bernier M, Baussart B, Foubert L, et al. Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol. 2014;81(4):566–72. DOI: 10.1111/cen.12443
Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB. Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab. 2005;90:3089–99. DOI: 10.1210/jc.2004-2231
